25766 Federal Register / Vol. 72, No. 87 / Monday, May 7, 2007 / Notices 

The HHS Appropriations Act requires 

that when issuing statements, press 

releases, requests for proposals, bid 

solicitations, and other documents 

describing projects or programs funded 

in whole or in part with Federal money, 

grantees shall clearly state the 

percentage and dollar amount of the 

total costs of the program or project 

which will be financed with Federal 

money, and the percentage and dollar 

amount of the total costs of the project 

or program that will be financed by nongovernmental sources. 

3. Reporting: Each year of the project 

period, the cooperative agreement 

recipient is required to submit a noncompeting application which includes 

an annual progress report for the current 

year, and a project work plan, budget, 

and budget justification for the 

upcoming year. The progress report 

should contain, at a minimum, a report 

on both process and outcome objectives, 

including evaluation of the activities as 

a whole, as well as for each component 

of NTC activities. 

For component requirements, the 

progress report should contain, at a 

minimum, information related to the 

following: 

Component A., Compile, Coordinate, 

and Disseminate Training Information: 

Obtaining and incorporating stakeholder 

input; gathering and cataloging training 

materials; design, implementation, and 

maintenance of NTC Web site; 

mechanisms for making information 

available; and, use of electronic 

technologies in addressing the 

requirements of this component. 

Component B., Conduct Training 

Meetings: (a) Title of training event; (b) 

location; (c) topic(s) covered; (d) 

presenter(s) (as applicable); (e) number 

of participants; (f) agencies sponsoring 

participants; and (g) evaluation 

summary (including whether meeting 

objectives were met); and, (h) credit 

hours or CEUs available. 

Component C., Develop Training 

Resources and/or Materials: The 

progress report should contain process 

and outcome information related to any 

materials developed as a result of this 

cooperative agreement. 

All information should be provided in 

adequate detail for the reviewer to 

assess the planning, implementation, 

evaluation, and status of project 

activities compared to the approved 

work plan. If deviations from the 

approved work plan were necessary, the 

progress report should fully explain and 

justify modifications. 

The work plan for the upcoming year 

should clearly reflect proposed NTC 

activities, including timeline; 

justification for any modifications from 

the previous year; S.M.A.R.T. objectives; 

and evaluation plan. The budget should 

reflect proposed costs to carry out the 

project plan. Sufficient detail should be 

provided so that the reviewer is able to 

determine the adequacy and 

appropriateness of budgeted items 

related to the proposed activities. 

The cooperative agreement recipient 

is required to submit an annual 

Financial Status Report (FSR) within 90 

days after the end of each budget period. 

Agencies that receive a total of $500,000 

or greater of Federal funds must 

undergo an independent audit in 

accordance with OMB Circular A–133. 

VII. Agency Contacts 

Administrative and Budgetary 

Requirements 

For application kits, submission of 

hard copy applications, and information 

on budget and business aspects of the 

application, please contact: WilDon 

Solutions, Office of Grants Management 

Operations Center, 1515 Wilson Blvd., 

Third Floor Suite 310, Arlington, VA 

22209 at 1–888–203–6161, e-mail 

OPHSgrantinfo@teamwildon.com, or fax 

703–351–1138. 

Program Requirements 

For information related to family 

planning program requirements, 

contact: WilDon Solutions, Office of 

Grants Management Operations Center, 

1515 Wilson Blvd., Third Floor Suite 

310, Arlington, VA 22209 at 1–888–

203–6161, e-mail 

OPHSgrantinfo@teamwildon.com, or fax 

703–351–1138. Identify that your 

inquiry is related to the Office of 

Population Affairs/Office of Family 

Planning program announcement for the 

National Family Planning Center 

Cooperative Agreement. 

VIII. Other Information 

Definitions: For the purposes of this 

announcement, the following 

definitions apply: 

Family planning training—jobspecific skill development, the purpose 

of which is to promote and improve the 

delivery of family planning services. 

Further description of family planning 

services may be found in the 

authorizing legislation, implementing 

regulations, and program guidelines. 

Application—a request for financial 

support of a project submitted to OPA 

on specified forms and in accordance 

with instructions provided. 

Cooperative Agreement—An award 

instrument of financial assistance where 

‘‘substantial involvement’’ is anticipated 

between the HHS awarding agency and 

the recipient during performance of the 

contemplated project or activity. 

‘‘Substantial involvement’’ means that 

the recipient can expect Federal 

programmatic collaboration or 

participation in managing the award. 

The entity that receives a Federal 

cooperative agreement assumes the legal 

and financial responsibility and 

accountability for the awarded funds 

and performance of activities approved 

for funding, and is held to all 

requirements for Federal grants. 

Evidence-based—relevant scientific 

evidence that has undergone 

comprehensive review and rigorous 

analysis. 

Project—those activities described in 

the application and supported under the 

approved budget. 

Technical Assistance Conference Call: 

There will be an opportunity for 

prospective applicants to participate in 

a technical assistance conference call to 

be held within one month after 

publication of this Notice in the Federal 

Register. For more information 

regarding this opportunity, including 

date, registration information, and how 

to join the call, please consult the OPA 

Web site at http://opa.osophs.dhhs.gov. 

Dated: May 1, 2007. 

Evelyn M. Kappeler, 

Acting Director, Office of Population Affairs. 

[FR Doc. E7–8668 Filed 5–4–07; 8:45 am] 

BILLING CODE 4150–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

National Advisory Council for 

Healthcare Research and Quality: 

Request for Nominations for Public 

Members 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for nominations for 

public members. 

SUMMARY: 42 U.S.C. 299c, section 931 of 

the Public Health Service (PHS Act), 

established a National Advisory Council 

for Healthcare Research and Quality (the 

Council). The Council is to advise the 

Secretary of HHS and the Director of the 

Agency for Healthcare Research and 

Quality (AHRQ) on matters related to 

actions of the Agency to improve the 

quality, safety, efficiency, and 

effectiveness of health care for all 

Americans. 

Seven current members’ terms will 

expire in November 2007. To fill these 

positions in accordance with the 

legislative mandate establishing the 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 87 / Monday, May 7, 2007 / Notices 25767 

Council, we are seeking individuals 

who are distinguished: (1) In the 

conduct of research, demonstration 

projects, and evaluations with respect to 

health care; (2) in the fields of health 

care quality research or health care 

improvement; (3) in the practice of 

medicine; (4) in other health 

professions; (5) in representing the 

private health care sector (including 

health plans, providers, purchasers) or 

administrators of health care delivery 

systems; (6) in the fields of health care 

economics, information systems, law, 

ethics, business, or public policy; and, 

(7) in representing the interests of 

patients and consumers of health care. 

Individuals are particularly sought with 

experience and success in activities 

specified in the summary above. 

DATES: Nominations should be received 

on or before June 15, 2007. 

ADDRESSES: Nominations should be sent 

to Ms. Deborah Queenan, AHRQ, 540 

Gaither Road, Room 3238, Rockville, 

Maryland 20850. Nominations also may 

be faxed to (301) 427–1341. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Deborah Queenan, AHRQ, at (301) 427–

1330. 

SUPPLEMENTARY INFORMATION: 42 U.S.C. 

299c, section 931, of the PHS Act, 

provides that the National Advisory 

Council for Healthcare Research and 

Quality shall consist of 21 appropriately 

qualified representatives of the public 

appointed by the Secretary of Health 

and Human Services and, in addition, 

ex officio representatives from other 

Federal agencies specified in the 

authorizing legislation, principally 

agencies that conduct or support health 

care research, as well as Federal officials 

the Secretary may consider appropriate. 

The Council meets in the Washington, 

DC., metropolitan area, generally in 

Rockville, Maryland, approximately 

three times a year to provide broad 

guidance to the Secretary and AHRQ’s 

Director on the direction of and 

programs undertaken by AHRQ. 

Seven individuals will be selected 

presently by the Secretary to serve on 

the Council beginning with the meeting 

in the spring of 2008. Members 

generally serve 3-year terms. 

Appointments are staggered to permit 

an orderly rotation of membership. 

Interested persons may nominate one 

or more qualified persons for 

membership on the Council. Selfnominations are accepted. Nominations 

shall include: (1) A copy of the 

nominee’s resume or curriculum vitae; 

and (2) a statement that the nominee is 

willing to serve as a member of the 

Council. Selected candidates will be 

asked to provide detailed information 

concerning their financial interests, 

consultant positions and research grants 

and contracts, to permit evaluation of 

possible sources of conflict of interest. 

The Department seeks a broad 

geographic representation and has 

special interest in assuring that women, 

minority groups, and the physically 

handicapped are adequately represented 

on advisory bodies, and therefore, 

particularly encourages nominations for 

appropriately qualified female, 

minority, and/or physically 

handicapped candidates. 

Dated: April 26, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–2239 Filed 5–4–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is group of 

experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for ‘‘Ambulatory Care 

Patient Safety Proactive Risk 

Assessment (P20),’’ are to be reviewed 

and discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: Ambulatory Care Patient 

Safety Proactive Risk Assessment (P20). 

Date: May 21–22, 2007 (Open on May 21 

from 8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting). 

Place: John M. Eisenberg Building, AHRQ 

Conference Center, 540 Gaither Road, 

Rockville, Maryland 20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

non-confidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: April 23, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–2238 Filed 5–2–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Pediatric Oncology Subcommittee of 

the Oncologic Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting is open to the 

public. 

Name of Committee: Pediatric 

Oncology Subcommittee of the 

Oncologic Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on June 27, 2007, from 8 a.m. to 4 

p.m. 

Location: Food and Drug 

Administration, Center for Drug 

Evaluation and Research Advisory 

Committee Conference Room, rm. 1066, 

5630 Fishers Lane, Rockville, MD. 

Contact Person: Mimi Phan, Center 

for Drug Evaluation and Research (HFD–

21), Food and Drug Administration, 

5600 Fishers Lane, (for express delivery, 

5630 Fishers Lane, rm. 1093), Rockville, 

MD 20857, 301–827–7001, FAX: 301–

827–6776, e-mail: 

Mimi.Phan@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512542. Please call the Information 

Line for up-to-date information on this 

meeting. 

Agenda: The subcommittee will do 

the following: (1) Discuss review of 


pwalker on PROD1PC71 with NOTICES